We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+16.22%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$720B
AUM Growth
+$134B
Cap. Flow
-$2.7B
Cap. Flow %
-0.37%
Top 10 Hldgs %
26.15%
Holding
14,080
New
1,720
Increased
5,716
Reduced
5,055
Closed
1,538

Sector Composition

Rank Sector Weight
1 Technology 1.79%
2 Consumer Discretionary 0.82%
3 Financials 0.79%
4 Healthcare 0.66%
5 Industrials 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INZY
11601
CALL
DELISTED
Inozyme Pharma
INZY
$132K ﹤0.01%
+33,000
New +$81.7K
RXD icon
11602
ProShares UltraShort Health Care
RXD
$2.9M
$132K ﹤0.01%
5,448
+151
+3% +$3.69K
ELTX icon
11603
Elicio Therapeutics
ELTX
$78.6M
$131K ﹤0.01%
17,023
-14,338
-46% -$89.2K
CRDF icon
11604
PUT
Cardiff Oncology
CRDF
$77.2M
$131K ﹤0.01%
41,700
+10,400
+33% +$31.7K
KURA icon
11605
CALL
Kura Oncology
KURA
$1.16B
$131K ﹤0.01%
22,700
-18,200
-44% -$112K
TRON
11606
PUT
Tron Inc
TRON
$1.01B
$131K ﹤0.01%
+16,900
New +$30.3K
PNNT
11607
Pennant Park Investment Corp
PNNT
$245M
$131K ﹤0.01%
19,148
-28,137
-60% -$186K
ADUR
11608
CALL
Aduro Clean Technologies
ADUR
$526M
$131K ﹤0.01%
+14,600
New +$101K
LUNG icon
11609
Pulmonx
LUNG
$110M
$130K ﹤0.01%
50,310
-5,920
-11% -$23.4K
MCRB icon
11610
Seres Therapeutics
MCRB
$47.9M
$130K ﹤0.01%
11,684
-24,173
-67% -$213K
MAZE
11611
Maze Therapeutics
MAZE
$1.56B
$130K ﹤0.01%
10,567
-41
-0.4% -$427
BRCC icon
11612
BRC Inc
BRCC
$122M
$130K ﹤0.01%
9,893
-5,567
-36% -$103K
OMEX icon
11613
CALL
Odyssey Marine Exploration
OMEX
$54M
$129K ﹤0.01%
109,600
-249,000
-69% -$227K
LFT
11614
Lument Finance Trust
LFT
$39.7M
$129K ﹤0.01%
58,366
-71,051
-55% -$179K
CLPT icon
11615
PUT
ClearPoint Neuro
CLPT
$494M
$129K ﹤0.01%
+10,800
New +$136K
CVGI icon
11616
Commercial Vehicle Group
CVGI
$127M
$129K ﹤0.01%
77,526
+3,492
+5% +$4.25K
DSGN icon
11617
Design Therapeutics
DSGN
$974M
$129K ﹤0.01%
38,170
-5,053
-12% -$18.9K
BERZ icon
11618
MicroSectors FANG & Innovation -3x Inverse Leveraged ETN
BERZ
$14.8M
$129K ﹤0.01%
1,124
+330
+42% +$67.2K
FCO
11619
DELISTED
abrdn Global Income Fund
FCO
$128K ﹤0.01%
20,082
+5,536
+38% +$33.8K
AGL icon
11620
PUT
Agilon Health
AGL
$1.59B
$128K ﹤0.01%
2,228
-11,184
-83% -$897K
ASG
11621
Liberty All-Star Growth Fund
ASG
$335M
$128K ﹤0.01%
+23,395
New +$118K
TBPH icon
11622
PUT
Theravance Biopharma
TBPH
$885M
$128K ﹤0.01%
+11,600
New +$113K
DMAC icon
11623
DiaMedica Therapeutics
DMAC
$365M
$128K ﹤0.01%
32,796
-523,797
-94% -$2.04M
JMM icon
11624
Nuveen Multi-Market Income Fund
JMM
$54.7M
$128K ﹤0.01%
+20,366
New +$124K
NXJ
11625
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
$128K ﹤0.01%
+11,264
New +$128K

Similar funds

Jeff Yass's Q2 2025 Portfolio in Review

As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jeff Yass's Q2 2025 filing shows 1,720 new, 5,716 increased, 5,055 reduced and 1,538 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B.

By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
  • Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
  • Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
  • Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
  • Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
  • Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
  • Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.